Housing permits surge in April

For the month of April, 104 Connecticut municipalities authorized 613 new housing units, according to the monthly housing report from the state’s Department of Economic & Community Development (DECD). That figure reflects a 53-percent increase from the 401 units that were green-lighted in March, as the spring construction season shifted into gear.

Locally the most active communities for building activity were Fairfield (21 new housing units permitted in April) and Milford (16 housing permits). The statewide leader in new housing permits was Stamford, with 330 for the month. The City of New Haven approved one new unit in April.

TRANSACTIONS

Historic High St. apartments sold

ADVERTISEMENT

Cambridge Oxford Apartments, a three-building, 84-unit multifamily property at 32-38 High St., New Haven, has been sold. The buyer is an affiliate of Paredim Partners LLC. Originally constructed between 1860 and 1926 and completely renovated in 2001, the complex is adjacent to the Yale Center for British Art and has long been popular with Yale Medical School faculty, staff and students. Institutional Property Advisors (IPA), a division of Marcus & Millichap, brokered the transaction.

***

Flexprint LLC has leased 12,975 square feet of industrial and office space at 55 Robinson Blvd., Orange. Based in Mesa, Az. the company, which provides managed print services, was represented by Robert Adnipoz of Collier International. The building owner ALM Properties II LLC and MCM Investments II LLC, was represented by Carl G. Russell, CCIM, SIOR of Pearce Commercial Real Estate’s Milford office.

ADVERTISEMENT

***

Margaret I. Chustecki has sold 4,433 square feet of office space at 98 Elm St., West Haven to Internal Medicine of Greater New Haven, a practice of internal-medicine practitioners. It is the third unit the practice has acquired in the building. The building owner was represented by Jed Backus of Backus Real Estate in Hamden, while Carl G. Russell, CCIM, SIOR of Pearce Commercial Real Estate, represented Internal Medicine in the deal.